Ardelyx (ARDX) Tax Provisions (2013 - 2026)

Ardelyx (ARDX) posted Tax Provisions of $8000.0 for Q1 2026, up 14.29% on a QoQ basis from $7000.0 in Q4 2025, and down 99.07% year-over-year from $859000.0 in Q1 2025.

Ardelyx (ARDX) Tax Provisions (2013 - 2026) Analysis & Trends

Ardelyx's Tax Provisions history runs 13 years deep, the most recent figure standing at $8000.0 for Q1 2026.

  • Quarterly Tax Provisions fell 99.07% year-over-year to $8000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $118000.0 (down 88.25% YoY) and the FY2025 annual result came in at $969000.0, up 264.29% from the prior year.
  • Tax Provisions was $8000.0 for Q1 2026 at Ardelyx, up from $7000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $859000.0 in Q1 2025 and bottomed at $1000.0 in Q2 2025.
  • A 5-year average of $128428.6 and a median of $39000.0 in 2024 frame the typical range for Tax Provisions.
  • Annual changes were most pronounced in 2024 — Tax Provisions soared 764.29% — and 2026, when it plunged 99.07%.
  • Ardelyx's Tax Provisions stood at $6000.0 in 2022, then soared by 5450.0% to $333000.0 in 2023, then tumbled by 89.49% to $35000.0 in 2024, then sank by 80.0% to $7000.0 in 2025, then gained by 14.29% to $8000.0 in 2026.
  • Business Quant data shows ARDX's Tax Provisions at $8000.0 in Q1 2026, $7000.0 in Q4 2025, and $102000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 125,146.46
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -859,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 31.86 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 221.50 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 104.00 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -60.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Ardelyx 1.24 Bn 999.81 Mn 89.66 Mn 8,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 8,000.00
Dec 31, 2025 7,000.00
Sep 30, 2025 102,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 859,000.00
Dec 31, 2024 35,000.00
Sep 30, 2024 43,000.00
Jun 30, 2024 67,000.00
Mar 31, 2024 121,000.00
Dec 31, 2023 333,000.00
Sep 30, 2023 200,000.00
Mar 31, 2023 14,000.00
Jun 30, 2022 6,000.00
Mar 31, 2022 2,000.00
Sep 30, 2021 1,000.00
Jun 30, 2021 2,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 2,000.00
Sep 30, 2019 301,000.00
Mar 31, 2019 2,000.00